Literature DB >> 22441550

[Spontaneous change of malignancy of solid malignant tumors : statistical investigations of colorectal and pancreatic carcinoma].

F Stelzner1.   

Abstract

The distribution curves of grades of malignancy for colorectal carcinomas and pancreatic carcinomas have not been stable over the years and investigations have shown a clear variability in the temporal distribution. Colon carcinomas were found to diminish considerably in aggressiveness in different time periods and colorectal carcinomas were found to increase in aggressiveness in some years. However, the distribution curve of grades of malignancy varies in both carcinomas over time and this variation follows a random distribution. In contrast to colorectal carcinomas, pancreatic carcinomas have not been followed up for very long time periods. While the distribution curve of malignancy was unchanged in most countries an increase in malignancy was observed in two countries. For colorectal and pancreatic carcinomas increases in malignancy are linked to a highly significant decrease in the number of cancers with lowest grades of malignancy. Even though the exact nature of variations in these malignancy distribution curves is incompletely understood, these variations appear important for comparative outcome statistics in cancer therapy as the aggressiveness of these malignancies has a direct bearing on the overall prognosis.

Entities:  

Mesh:

Year:  2012        PMID: 22441550     DOI: 10.1007/s00104-011-2236-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  12 in total

1.  [PET-CT studies of metastasizing cancer of the colon and rectum. Variability of tumor aggressiveness as a micro-evolutionary process of cancer stem cells with predetermined prognosis].

Authors:  F Stelzner; D von Mallek; J Ruhlmann; H J Biersack
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

2.  [Autoregulatory growth control of adenomatous polyps and carcinogenesis in the colorectal region. Basics of tumor surgery Part I].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

3.  Comparative results of surgical management of single carcinomas of the colon and rectum: a series of 1939 patients managed by one surgeon.

Authors:  F T McDermott; E S Hughes; E Pihl; B J Milne; A B Price
Journal:  Br J Surg       Date:  1981-12       Impact factor: 6.939

4.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

5.  Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.

Authors:  C J Yeo; J L Cameron; T A Sohn; K D Lillemoe; H A Pitt; M A Talamini; R H Hruban; S E Ord; P K Sauter; J Coleman; M L Zahurak; L B Grochow; R A Abrams
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

7.  Pancreaticoduodenectomy: a 20-year experience in 516 patients.

Authors:  C Max Schmidt; Emilie S Powell; Constantin T Yiannoutsos; Thomas J Howard; Eric A Wiebke; Chad A Wiesenauer; Joel A Baumgardner; Oscar W Cummings; Lewis E Jacobson; Thomas A Broadie; David F Canal; Robert J Goulet; Eardie A Curie; Higinia Cardenes; John M Watkins; Patrick J Loehrer; Keith D Lillemoe; James A Madura
Journal:  Arch Surg       Date:  2004-07

8.  Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

Authors:  Hans G Smeenk; Casper H J van Eijck; Wim C Hop; Joris Erdmann; Kheetje C K Tran; Muriel Debois; Eric van Cutsem; Herman van Dekken; Jean H Klinkenbijl; Johannes Jeekel
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

9.  Changing survival prospects in carcinoma of the rectum.

Authors:  F T McDermott; E S Hughes; E A Pihl; B J Milne
Journal:  Br J Surg       Date:  1980-11       Impact factor: 6.939

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

View more
  5 in total

1.  Nitric oxide represses the proliferation of Caco-2 cells by inducing S-G2/M cell cycle arrest.

Authors:  Satoru Sakuma; Yukino Ikeda; Itsumi Inoue; Kanna Yamaguchi; Shohko Honkawa; Tetsuya Kohda; Saaya Minamino; Yohko Fujimoto
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 2.  [Surgery without anatomy?].

Authors:  F Stelzner
Journal:  Chirurg       Date:  2016-08       Impact factor: 0.955

3.  [Prediction of prognosis of pancreatic cancer based on the homing area].

Authors:  F Stelzner; J Ruhlmann; D von Mallek
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

4.  Hydrogen peroxide generated by xanthine/xanthine oxidase system represses the proliferation of colorectal cancer cell line Caco-2.

Authors:  Satoru Sakuma; Muneyuki Abe; Tetsuya Kohda; Yohko Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

5.  Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death.

Authors:  Satoru Sakuma; Saaya Minamino; Maya Takase; Yoshitaka Ishiyama; Hiroyuki Hosokura; Tetsuya Kohda; Yukino Ikeda; Yohko Fujimoto
Journal:  Heliyon       Date:  2019-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.